Compare RAPP & IRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
Current Price
| Metric | RAPP | IRS |
|---|---|---|
| Founded | 2022 | 1943 |
| Country | United States | Argentina |
| Employees | N/A | 1392 |
| Industry | | Homebuilding |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2024 | N/A |
| Metric | RAPP | IRS |
|---|---|---|
| Price | $27.56 | $14.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $48.50 | N/A |
| AVG Volume (30 Days) | ★ 292.7K | 170.5K |
| Earning Date | 03-10-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 9.67% |
| EPS Growth | ★ 24.34 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.66 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.73 | $10.61 |
| 52 Week High | $42.27 | $19.14 |
| Indicator | RAPP | IRS |
|---|---|---|
| Relative Strength Index (RSI) | 45.93 | 36.38 |
| Support Level | $26.67 | $11.11 |
| Resistance Level | $29.51 | $16.37 |
| Average True Range (ATR) | 1.88 | 0.70 |
| MACD | -0.30 | -0.06 |
| Stochastic Oscillator | 29.46 | 7.84 |
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segments include Shopping Malls, which comprise lease and service revenues principally related to the rental of commercial and other spaces in the company's shopping malls; Offices, which include lease revenues and other service revenues related to office activities; Sales and Developments, which include the development, maintenance, and sales of undeveloped parcels of land and/or trading properties; Hotels, which mainly include revenues from rooms, catering, and restaurants; and others. The company generates the majority of its revenue from the Shopping Malls segment.